Published in Law and Health Weekly, August 14th, 2004
Cloudsdale will apply his 20 years of experience in small molecule discovery and management initialing on the new PBMR focused library sets such as GPCR, ion channel blocker & kinase inhibitors plus leading the PBMR expanding lead optimization services. Cloudsdale will head the development of new business opportunities with PBMR's customers, and lead PBMR's business expansion efforts in the custom chemistry area.
He has a broad chemical background ranging from small molecule discovery to early process research. As director of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.